<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03312816</url>
  </required_header>
  <id_info>
    <org_study_id>FDS-SCC-2838</org_study_id>
    <nct_id>NCT03312816</nct_id>
  </id_info>
  <brief_title>Effect of Oxidized Plant Sterols on Serum Concentrations of Plant Sterol Oxidation Products (POP)</brief_title>
  <official_title>The Effect of Oxidized Plant Sterol Intake on Serum Concentrations of Plant Sterol Oxidation Products (POP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Unilever R&amp;D</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a randomised, double-blind, placebocontrolled, parallel dose-response study with
      four study arms. Sixty subjects will be randomly allocated to consume study products
      containing varying amounts of plant sterol (PS) oxidation products (POP) or placebo for 6
      weeks.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 16, 2017</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>POP (plant sterol oxidation products) value</measure>
    <time_frame>0 to 42 days</time_frame>
    <description>To estimate the change from baseline in serum POP concentration after intake of various POP doses.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>COP (cholesterol oxidation products) value</measure>
    <time_frame>0 to 42 days</time_frame>
    <description>To estimate the change from baseline in serum COP concentrations after intake of various POP doses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of serum POP concentration</measure>
    <time_frame>0 to 42 days</time_frame>
    <description>To estimate the ratio of serum POP concentrations vs. COP concentrations after intake of various POP doses.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0 mg/d added POP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low dosage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>low added POP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medium dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>medium added POP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hige dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>high added POP</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cookies enriched with POP</intervention_name>
    <description>Cookies</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>low dosage</arm_group_label>
    <arm_group_label>Medium dose</arm_group_label>
    <arm_group_label>Hige dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Apparently healthy men and women as judged by study physician.

          -  BMI &gt; 18 and &lt; 35 kg/m2.

          -  Total cholesterol levels at screening ≥5.0 and ≤8.0 mmol/L

          -  Blood pressure, heart rate, haematological and clinical chemical parameters within the
             normal reference range as judged by the study physician.

        Exclusion Criteria:

          -  Recently (&lt;6 months) diagnosed with cardiovascular event(s) (stroke, TIA (Transient
             ischemic attack), angina, myocardial infarction, heart failure), revascularization or
             systemic inflammatory conditions.

          -  Use of plant-sterol/stanol-enriched foods or supplements in the three months prior to
             the screening and/or during the study.

          -  Use of over-the-counter and prescribed medication which may interfere with study
             measurements (i.e. statins, ezetimibe, fibrates, diabetic drugs, angiotensin receptor
             blockers (ARB) and ACE (Angiotensin-converting enzyme) inhibitors)), to be judged by
             the principal investigator.

          -  Use of oral antibiotics (with the exception of topical antibiotics) in 40 days or less
             prior to Day -2.

          -  Pregnant or lactating women.

          -  Reported alcohol consumption &gt; 14 units/week (female) or &gt; 21 units/week (male).

          -  Reported intense sporting activities &gt; 10 hours/week.

          -  Reported weight loss or gain of 3 kg or more during a period of 6 months prior to
             screening.

          -  Currently on a medically- or self-prescribed diet, or slimming diet, or the intention
             to use any kind of diet during the study.

          -  Currently smoking or being a non-smoker for less than 6 months and reported use of any
             nicotine containing products in the 6 months prior to screening and/or during the
             study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Keicher, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité Research Organisation GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne-Roos Hoogenraad</last_name>
    <phone>+31 6 8120 2724</phone>
    <email>Anne-Roos.Hoogenraad@unilever.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Charité Research Organisation GmbH</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Keicher, Dr. med.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2017</study_first_submitted>
  <study_first_submitted_qc>October 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2017</study_first_posted>
  <last_update_submitted>December 1, 2017</last_update_submitted>
  <last_update_submitted_qc>December 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

